Abstract
Metastatic ovarian cancer is a significant clinical challenge due in part to its poor response to immunotherapy. In a recent issue of Cancer Cell, Anandon etal. (2022) identify a population of stem-like tissue-resident memory Tcells that are responsible for the bulk of anti-tumor Tcell immunity, with insights into improving therapeutic response.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
